| Literature DB >> 35594622 |
Omar Asdrúbal Vilca Mejia1, Frederico Carlos Cordeiro de Mendonça2, Lucimar Aparecida Barrense Nogueira Sampaio3, Filomena Regina Barbosa Gomes Galas4, Mauricio Franklin Pontes5, Luiz Fernando Caneo2, Luís Roberto Palma Dallan2, Luiz Augusto Ferreira Lisboa2, João Fernando Monteiro Ferreira6, Luís Alberto de Oliveira Dallan2, Fabio Biscegli Jatene2.
Abstract
OBJECTIVE: To evaluate the impact of adherence to the cardiac surgical checklist on mortality at the teaching hospital.Entities:
Keywords: Cardiac surgery; Checklists; Mortality; Quality improvement
Mesh:
Year: 2022 PMID: 35594622 PMCID: PMC9123198 DOI: 10.1016/j.clinsp.2022.100048
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.898
Characteristics of the population analyzed: clinical and pre-operative parameters.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | n | % | N | % | n | % | n | % | n | % | n | % | n | % |
| CABG | 584 | 51.1% | 614 | 51.0% | 622 | 52.4% | 549 | 51.7% | 523 | 52.2% | 554 | 51.6% | 700 | 47.6% |
| CABG + valve surgery | 87 | 7.61% | 89 | 7.04% | 61 | 5.13% | 40 | 3.77% | 67 | 6.69% | 46 | 4.28% | 91 | 6.19% |
| Mitral valve surgery | 212 | 18.5% | 234 | 19.4% | 255 | 21.5% | 225 | 21.2% | 187 | 18.7% | 198 | 18.4% | 374 | 25.5% |
| Aortic valve surgery | 211 | 18.5% | 215 | 17.9% | 187 | 15.7% | 193 | 18.2% | 166 | 16.6% | 211 | 19.6% | 215 | 14.6% |
| Mitral + aortic valve surgery | 49 | 4.29% | 51 | 4.24% | 63 | 5.03% | 54 | 5.09% | 58 | 5.79% | 65 | 6.05% | 89 | 6.06% |
| Elective | 1015 | 88.8% | 1057 | 87.9% | 1046 | 88.0% | 787 | 74.2% | 734 | 73.3% | 778 | 72.4% | 1125 | 76.6% |
| Urgency | 128 | 11.2% | 146 | 12.1% | 142 | 11.9% | 274 | 25.8% | 267 | 26.7% | 296 | 27.6% | 344 | 23.4% |
| 63 | (54‒70) | 63 | (54‒70) | 62 | (54‒69) | 61 | (52‒68) | 62 | (54‒69) | 62 | (53‒69) | 61 | (53‒68) | |
| Male | 704 | 61.6% | 762 | 63.3% | 726 | 61.1% | 670 | 63.1% | 616 | 61.5% | 648 | 60.3% | 883 | 60.1% |
| Female | 438 | 38.3% | 441 | 36.7% | 462 | 38.9% | 391 | 36.8% | 385 | 38.5% | 426 | 39.6% | 585 | 39.8% |
| 389 | 34.0% | 460 | 38.2% | 487 | 41.0% | 381 | 35.9% | 377 | 37.7% | 357 | 33.2% | 526 | 35.8% | |
| 26 | 2.27% | 16 | 1.33% | 19 | 1.06% | 17 | 1.06% | 19 | 1.09% | 19 | 1.77% | 32 | 2.18% | |
| 133 | 11.6% | 116 | 9.64% | 109 | 9.18% | 102 | 9.61% | 127 | 12.7% | 106 | 9.87% | 153 | 10.4% | |
| 11 | 0.96% | 11 | 0.91% | 14 | 1.18% | 26 | 2.45% | 25 | 2.05% | 23 | 2.14% | 27 | 1.84% | |
| 24 | 2.1% | 16 | 1.33% | 13 | 1.09% | 19 | 1.79% | 14 | 1.04% | 17 | 1.58% | 29 | 1.97% | |
| 60 | 5.25% | 61 | 5.07% | 52 | 4.38% | 36 | 3.39% | 32 | 3.02% | 32 | 2.98% | 53 | 3.61% | |
| 29 | 2.54% | 28 | 2.33% | 26 | 2.19% | 20 | 1.89% | 20 | 1.99% | 24 | 2.23% | 34 | 2.31% | |
| 60 | (50‒64) | 61 | (55‒64) | 61 | (55‒64) | 61 | (55‒64) | 61 | (55‒64) | 61 | (55‒65) | 60 | (55‒64) | |
| 1.98 | ±1.13 | 1.51 | ±0.53 | 2.53 | ±2.92 | 2.72 | ±4.58 | 2.52 | ±4.22 | 2.51 | ±4.23 | 2.48 | ±4.31 | |
| I | 8 | 0.69% | 7 | 0.58% | 9 | 0.76% | 6 | 0.57% | 6 | 0.06% | 6 | 0.56% | 8 | 0.54% |
| II | 1126 | 98.5% | 1189 | 98.8% | 1169 | 98.4% | 1033 | 97.4% | 972 | 97.1% | 1054 | 98.1% | 1436 | 97.7% |
| III | 6 | 0.52% | 7 | 0.58% | 8 | 0.67% | 19 | 1.79% | 20 | 2.00% | 12 | 1.12% | 19 | 1.29% |
| IV | 3 | 0.26% | 0 | 0% | 2 | 0.17% | 3 | 0.28% | 3 | 0.03% | 2 | 0.19% | 6 | 0.41% |
| I | 1 | 0.09% | 1 | 0.08% | 2 | 0.17% | 0 | 0% | 2 | 0.02% | 0 | 0% | 0 | 0% |
| II | 42 | 3.67% | 41 | 3.41% | 29 | 2.44% | 24 | 2.26% | 17 | 1.07% | 51 | 4.75% | 49 | 3.34% |
| III | 681 | 59.6% | 613 | 51.0% | 718 | 60.4% | 654 | 61.6% | 594 | 59.3% | 691 | 64.3% | 923 | 62.8% |
| IV | 416 | 36.4% | 544 | 45.2% | 435 | 36.6% | 383 | 36.1% | 386 | 38.6% | 328 | 30.5% | 497 | 33.8% |
| v | 3 | 0.26% | 4 | 0.33% | 4 | 0.34% | 0 | 0% | 2 | 0.02% | 4 | 0.37% | 0 | 0% |
| 53 | 4.64% | 46 | 3.82% | 44 | 3.07% | 45 | 4.24% | 27 | 2.69% | 32 | 2.98% | 77 | 5.24% | |
| 74 | 6.47% | 89 | 7.04% | 97 | 8.16% | 112 | 10.6% | 105 | 10.5% | 99 | 9.22% | 139 | 9.46% | |
| 97 | 8.49% | 86 | 7.15% | 77 | 6.48% | 72 | 6.79% | 66 | 6.59% | 64 | 5.96% | 116 | 7.9% | |
| 19 | 1.66% | 17 | 1.41% | 15 | 1.26% | 16 | 1.51% | 17 | 1.07% | 17 | 1.58% | 37 | 2.52% | |
| 9 | 0.79% | 14 | 1.16% | 6 | 0.51% | 6 | 0.57% | 3 | 0.3% | 1 | 0.09% | 15 | 1.02% | |
| 18 | 1.57% | 13 | 1.08% | 15 | 1.26% | 9 | 0.85% | 10 | 1% | 13 | 1.21% | 25 | 1.07% | |
| 15 | 1.31% | 8 | 0.67% | 11 | 0.93% | 11 | 1.04% | 7 | 0.07% | 13 | 1.21% | 19 | 1.29% | |
| 9 | 0.79% | 8 | 0.67% | 7 | 0.59% | 15 | 1.41% | 18 | 1.8% | 5 | 0.47% | 19 | 1.29% | |
| 16 | 1.04% | 20 | 1.66% | 14 | 1.18% | 5 | 0.47% | 8 | 0.08% | 7 | 0.65% | 12 | 0.82% | |
| 31 | 2.71% | 23 | 1.91% | 31 | 2.61% | 24 | 2.26% | 20 | 2% | 18 | 1.68% | 35 | 2.38% | |
| 67 | 5.86% | 69 | 5.74% | 84 | 7.07% | 67 | 6.31% | 48 | 4.8% | 50 | 4.66% | 67 | 4.56% | |
IQR, Interquartile Range 25% and 75%.
American Society of Anesthesiologists.
§Defined as the inability of the heart to provide the necessary blood flow for the vital organs (cardiac failure without ventricular failure, ventricular failure with or without abnormal ventricular systolic function, prolonged tachycardias or tachyarrhythmias in normal hearts).
Characteristics of the population analyzed: outcomes and hospital stay.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | n | % | n | % | n | % | n | % | n | % | n | % | n | % |
| 124 | 10.8% | 156 | 13.0% | 113 | 9.51% | 101 | 9.52% | 73 | 7.29% | 55 | 5.12% | 143 | 9.73% | |
| 154 | 13.5% | 134 | 11.1% | 161 | 13.5% | 126 | 11.9% | 191 | 19.1% | 307 | 28.6% | 371 | 25.3% | |
| 5.10 | (1.10‒10.5) | 3.00 | (1.00‒7.40) | 3.60 | (0.90‒7.40) | 2.80 | (0.90‒6.90) | 2.10 | (0.80‒6.50) | 1.70 | (0.80‒5.80) | 1.10 | (0.70‒40.7) | |
| 6.83 | (6.00‒7.75) | 6.83 | (6.08‒7.67) | 6.62 | (6.17‒7.83) | 7.00 | (6.33‒7.95) | 7.25 | (6.42‒8.25) | 7.12 | (6.25‒8.17) | 6.83 | (6.08‒7.67) | |
| 9.25 | (7.10‒15.8) | 9.10 | (7.00‒14.8) | 9.00 | (7.00‒14.0) | 8.10 | (6.80‒12.5) | 8.80 | (6.90‒14.8) | 8.00 | (6.70‒13.8) | 8.90 | (6.90‒14.5) | |
| 17.0 | (11.1‒27.6) | 15.0 | (10.0‒22.9) | 14.5 | (9.40‒21.9) | 13.7 | (9.00‒20.4) | 13.4 | (9.10‒21.7) | 12.7 | (8.60‒19.9) | 12.4 | (8.80‒18.9) | |
| 94 | 8.22% | 82 | 6.82% | 89 | 7.49% | 69 | 6.5% | 57 | 5.69% | 50 | 4.66% | 46 | 3.13% | |
This analysis does not include aortic and congenital surgeries.
IQR, Interquartile Range 25% and 75%.
Fig. 1Study design flowchart.
Questionnaire on the need for implementation of the InCor-Checklist (12/08/2014).
| Questionnaire | Answer |
|---|---|
| I believe that the InCor-Checklist will make the surgical team better able to perform safe surgeries | 4.86 ± 0.4 |
| I believe that the InCor-Checklist will be easy to use | 4.01 ± 0.9 |
| I would use the InCor-Checklist if I was part of the surgical team | 4.98 ± 0.1 |
| If I had an operation, I would like the surgical team to use the checklist | 4.94 ± 0.2 |
Score ranges from 1 (completely disagree) to 5 (completely agree).
Fig. 2InCor-Checklist “Five Steps to Safe Surgery” form.
Fig. 3Interventions in the InCor-Checklist use and the association of adherence to the instrument and surgical mortality over time.
Adherence to the 5 phases of the InCor-Checklist in the analyzed period.
| Year | Number of surgeries | Mortality | InCor-Checklist use | Checklist completeness (5 phases) |
|---|---|---|---|---|
| 2013 | 1143 | 8.22% | 0% | ‒ |
| 2014 | 1203 | 6.82% | 0% | ‒ |
| 2015 | 1188 | 7.49% | 58% | 3.3 |
| 2016 | 1061 | 6.5% | 75% | 3.2 |
| 2017 | 1001 | 5.69% | 72% | 3.1 |
| 2018 | 1074 | 4.66% | 94% | 3.6 |
| 2019 | 1469 | 3.13% | 100% | 3.9 |
∼ Approximately.